Table 4.
Reasons for SMA appointment cancellations and/or delays, as reported by care-and-trial sites and care sites
| Types of appointment cancellations/delays | ||||||||
|---|---|---|---|---|---|---|---|---|
| Appointment for SMA carea | Appointment for SMA treatmenta | Appointment for SMA-related servicesa | Clinical trial | |||||
| Care-and-trial sites (n = 18) % (n) |
Care sites (n = 13) % (n) |
Care-and-trial sites (n = 7) % (n) |
Care sites (n = 6) % (n) |
Care-and-trial sites (n = 21) % (n) |
Care sites (n = 16) % (n) |
Care-and-trial sites (n = 26) % (n) |
Care sites (n = 22) % (n) |
|
| Executive orders by state on dental, medical and surgical procedures | 61.1% (11) | 61.5% (8) | 28.6% (2) | 66.7% (4) | 47.6% (10) | 62.5% (10) | 26.9% (7) | – |
| Executive orders by city on dental, medical and surgical procedures | 44.4% (8) | 30.8% (4) | 0% (0) | 33.3% (2) | 33.3% (7) | 25.0% (4) | 26.9% (7) | – |
| Hospital and/or clinic administration deemed appointment non-emergent | 72.2% (13) | 53.8% (7) | 28.6% (2) | 50.0% (3) | 81.0% (17) | 68.8% (11) | 46.2% (12) | – |
| Provider deemed appointment non-emergent | 72.2% (13) | 61.5% (8) | 28.6% (2) | 33.3% (2) | 61.9% (13) | 56.3% (9) | 30.8% (8) | – |
| Delays due to exposure of clinic staff to COVID-19 | 5.6% (1) | 0% (0) | 28.6% (2) | 0% (0) | 4.8% (1) | 0% (0) | 3.8% (1) | – |
| Delays due to clinic staff testing positive for COVID-19 | 11.1% (2) | 0% (0) | 14.3% (1) | 0% (0) | 4.8% (1) | 6.3% (1) | 3.8% (1) | – |
| Changes in the clinical trials protocol or informed consent | – | – | – | – | – | – | 30.8% (8) | – |
aRespondents of the Provider Impact Survey were asked to identify the cause of reported appointment cancellations or delays. Sample size reflects number of respondents that previously reported the type of appointment cancellations/delays occurred at any time within their clinic as a result of the pandemic